nadph- cyt. p450 reductase p450 s soh o 2 h 2 o e nadph nadp +
TRANSCRIPT
![Page 1: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/1.jpg)
![Page 2: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/2.jpg)
NADPH-Cyt. P450 reductase
P450P450
S
SOH
O2 H2O
e
NADPH
NADP+
![Page 3: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/3.jpg)
![Page 4: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/4.jpg)
Aromatic hydroxylation
OH
![Page 5: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/5.jpg)
Aliphatic hydroxylation
CH2 CH3 CH2 CH2OH
![Page 6: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/6.jpg)
Epoxidation
![Page 7: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/7.jpg)
Dealkylation
O
CH3O
NCH3
HO
O
HO
NCH3
HO
+ HCHO
Codeine Morphine
![Page 8: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/8.jpg)
![Page 9: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/9.jpg)
CYP1A
• Metabolize polycyclic hydrocarbons • Are induced by polycyclic hydrocarbons
– Found in cigarette smoke– Associated with cancer
• CYP1A1 – is inducible– extrahepatic
• CYP1A2 – is constitutively expressed only in liver– Is inducible
![Page 10: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/10.jpg)
CYP1A
• Polymorphisms (primarily CYP1A1)– Expression polymorphism– Structural gene polymorphism
• In vivo assay (CYP1A2)– Caffeine metabolism
![Page 11: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/11.jpg)
CYP 2A
• CYP2A6 and CYP2A13– CYP2A6 is polymorphic– Responsible for nicotine metabolism
CYP 2B•CYP2B6
– CYP2B1 and CYP2B2 are major forms in rats–was originally thought to be a minor form in humans
![Page 12: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/12.jpg)
CYP2C
• CYP2C8, CYP2C9, CYP2C18, and CYP2C19 are major forms in humans
• Hormonally regulated in rodents (growth hormone)
• Metabolize about 30% of commonly used drugs– Omeprazole– Diazepam
• In vivo substrates– S-mephenytoin (CYP2C19)– Flurbiprofen (CYP2C9)
![Page 13: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/13.jpg)
CYP2D6
• Metabolize many important drugs– Codeine– Dextromethorphan
• Polymorphisms– Mutation in the structural gene– Related to increased cancer risk (rapid metabolizers)
• In vivo substrate– Debrisoquine– Dextromethorphan
![Page 14: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/14.jpg)
CYP2E1
• Is uncoupled– Produces superoxide and hydrogen peroxide
• Forms reactive intermediates– Nitrosamine carcinogens– acetaminophen
![Page 15: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/15.jpg)
CYP2E1
• Is uncoupled • Forms reactive intermediates
– Associated with acetaminophen toxicity
• Ethanol inducible• Polymorphisms
– Linked to cancer – Role in alcohol-related liver dysfunction
• In vivo substrate– chlorzoxazone
![Page 16: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/16.jpg)
CYP3A4/5
• Major P450 in humans - metabolizes over 50% of commonly used drugs
• Is inducible by numerous drugs
• CYP3A4 not polymorphic – but wide variation in activity (due to CYP3A5)
• In vivo substrates (hepatic and intestinal)– Erythromycin– Alfentanil
![Page 17: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/17.jpg)
Hydrolysis reactions
• Plasma, liver, kidney, and all tissues• Esterase
– Succinylcholine apnea
• Amidase• Epoxide hydrolase
– Found in liver and all tissues– Both microsomal and soluble forms– Inducible by phenobarbital and 3-
methylcholanthrene
![Page 18: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/18.jpg)
Hydrolysis reactions
• Esterase (plasma, liver, and kidney)– Succinylcholine apnea
• Amidase (liver)
• Epoxide hydrolase– Found in liver and all tissues– Both microsomal and soluble forms– Inducible by phenobarbital and 3-
methylcholanthrene
![Page 19: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/19.jpg)
![Page 20: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/20.jpg)
Hydrolysis reactions
• Esterase (plasma, liver, and kidney)– Succinylcholine apnea
• Amidase (liver)
• Epoxide hydrolase– Found in liver and all tissues– Both microsomal and soluble forms– Inducible by phenobarbital and 3-
methylcholanthrene
![Page 21: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/21.jpg)
Conjugations reactions(phase 2)
• Glucuronidation
• Sulfate conjugation
• Acetylation
• Glutathione conjugation
• Methylation
• Glycine conjugation
![Page 22: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/22.jpg)
Acetylation
N C
O
NH
NH2
N C
O
NH
NH
C
CH3
O
Acetyl CoA
N-acetyl transferase
![Page 23: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/23.jpg)
Glutathione conjugation
OS
H2C
HC
H2C
NH
C
CH2
CH2
CHNH2
COOH
HN
H2C COOHH
OHH
![Page 24: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/24.jpg)
Methylation• Methytransferases
• Cytoplasm and endoplasmic reticulum
• S-adenosymethionine
Amino acid conjugation• Usually as glycine conjugates
• Mitochonria and cytoplasm
![Page 25: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/25.jpg)
![Page 26: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/26.jpg)
eliminationA Aabsorption
Total Body Volume
A
![Page 27: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/27.jpg)
distribution
Central compartment
A
A
A Aabsorption elimination
![Page 28: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/28.jpg)
One Compartment Model
Intravascular Bolus
![Page 29: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/29.jpg)
0 2 4 6 8 10 12 140
10
20
30
Time (h.)
[dru
g]
in p
lasm
a
g/1
00 m
l
0 4 8 120.5
5.0
50.0
Time (h.)[d
rug]
in
plas
ma
g/
100
ml
![Page 30: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/30.jpg)
0 2 4 6 8 10 12 140
10
20
30
Time (h.)
[dru
g] i
n pl
asm
a
g/10
0 m
l
zero order
first order
0 4 8 120.5
5.0
50.0
Time (h.)
[dru
g] i
n pl
asm
a
g/10
0 m
l
zero order
1st order
![Page 31: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/31.jpg)
One Compartment Model
Extravascular
![Page 32: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/32.jpg)
0 10 20 30 40 500
10
20
30
Time (h.)
[dru
g] i
n pl
asm
a
g/10
0 m
l
0 10 20 30 40 501
10
100
Time (h.)
[dru
g] i
n pl
asm
a
g/10
0 m
l
![Page 33: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/33.jpg)
Effect of absorption rate constant
0 10 20 30 40 500
10
20
ka=1.39
ka=0.693
ka=0.277
ka=0.069
Time (h.)
[dru
g] i
n pl
asm
a
g/1
00 m
l
![Page 34: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/34.jpg)
Two Compartment Model
Intravascular Bolus
![Page 35: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/35.jpg)
0 2 4 6 8 10 12 140
25
50
75
Time (h.)
[dru
g] i
n p
lasm
a g
/100
ml
0 4 8 12 16 20 241
10
100
Time (h.)
[dru
g] i
n p
lasm
a g
/100
ml
![Page 36: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/36.jpg)
Two Compartment Model
Extravascular
![Page 37: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/37.jpg)
0 4 8 12 16 20 240
10
20
30
40
50
Time (h.)
[dru
g] i
n p
lasm
a g
/100
ml
0 10 20 30 401
10
100
Time (h.)
[dru
g] in
pla
sma
g/L
iter
![Page 38: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/38.jpg)
Apparent Volume of Distribution
![Page 39: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/39.jpg)
0 4 8 120.5
5.0
50.0 Cop
Time (h.)
[dru
g] i
n pl
asm
a
g/10
0 m
l
![Page 40: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/40.jpg)
![Page 41: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/41.jpg)
Continuous IV Infusion
![Page 42: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/42.jpg)
Multiple IV Administration
![Page 43: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/43.jpg)
Multiple Extravascular Administration
![Page 44: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/44.jpg)
![Page 45: NADPH- Cyt. P450 reductase P450 S SOH O 2 H 2 O e NADPH NADP +](https://reader036.vdocuments.us/reader036/viewer/2022081418/56649ed15503460f94be073b/html5/thumbnails/45.jpg)
0 4 8 120.5
5
50 Cop
Time (h.)
[dru
g] i
n p
lasm
a g
/100
ml